Global Angiotensin Receptor Antagonists Market Insights and Forecast to 2026

Global Angiotensin Receptor Antagonists Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Angiotensin Receptor Antagonists Product Introduction
1.2 Market Segments
1.3 Key Angiotensin Receptor Antagonists Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Angiotensin Receptor Antagonists Market Size Growth Rate by Type
1.4.2 Valsartan
1.4.3 Telmisartan
1.4.4 Losartan
1.4.5 Irbesartan
1.4.6 Azilsartan
1.4.7 Olmesartan
1.5 Market by Application
1.5.1 Global Angiotensin Receptor Antagonists Market Size Growth Rate by Application
1.5.2 Hypertension
1.5.3 Cardiovascular Diseases
1.5.4 Kidney Diseases
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Angiotensin Receptor Antagonists Market Size, Estimates and Forecasts
2.1.1 Global Angiotensin Receptor Antagonists Revenue 2015-2026
2.1.2 Global Angiotensin Receptor Antagonists Sales 2015-2026
2.2 Global Angiotensin Receptor Antagonists, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Angiotensin Receptor Antagonists Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Angiotensin Receptor Antagonists Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Angiotensin Receptor Antagonists Competitor Landscape by Players
3.1 Angiotensin Receptor Antagonists Sales by Manufacturers
3.1.1 Angiotensin Receptor Antagonists Sales by Manufacturers (2015-2020)
3.1.2 Angiotensin Receptor Antagonists Sales Market Share by Manufacturers (2015-2020)
3.2 Angiotensin Receptor Antagonists Revenue by Manufacturers
3.2.1 Angiotensin Receptor Antagonists Revenue by Manufacturers (2015-2020)
3.2.2 Angiotensin Receptor Antagonists Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Angiotensin Receptor Antagonists Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Angiotensin Receptor Antagonists Revenue in 2019
3.2.5 Global Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Angiotensin Receptor Antagonists Price by Manufacturers
3.4 Angiotensin Receptor Antagonists Manufacturing Base Distribution, Product Types
3.4.1 Angiotensin Receptor Antagonists Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Angiotensin Receptor Antagonists Product Type
3.4.3 Date of International Manufacturers Enter into Angiotensin Receptor Antagonists Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Angiotensin Receptor Antagonists Market Size by Type (2015-2020)
4.1.1 Global Angiotensin Receptor Antagonists Sales by Type (2015-2020)
4.1.2 Global Angiotensin Receptor Antagonists Revenue by Type (2015-2020)
4.1.3 Angiotensin Receptor Antagonists Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Angiotensin Receptor Antagonists Market Size Forecast by Type (2021-2026)
4.2.1 Global Angiotensin Receptor Antagonists Sales Forecast by Type (2021-2026)
4.2.2 Global Angiotensin Receptor Antagonists Revenue Forecast by Type (2021-2026)
4.2.3 Angiotensin Receptor Antagonists Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Angiotensin Receptor Antagonists Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Angiotensin Receptor Antagonists Market Size by Application (2015-2020)
5.1.1 Global Angiotensin Receptor Antagonists Sales by Application (2015-2020)
5.1.2 Global Angiotensin Receptor Antagonists Revenue by Application (2015-2020)
5.1.3 Angiotensin Receptor Antagonists Price by Application (2015-2020)
5.2 Angiotensin Receptor Antagonists Market Size Forecast by Application (2021-2026)
5.2.1 Global Angiotensin Receptor Antagonists Sales Forecast by Application (2021-2026)
5.2.2 Global Angiotensin Receptor Antagonists Revenue Forecast by Application (2021-2026)
5.2.3 Global Angiotensin Receptor Antagonists Price Forecast by Application (2021-2026)
6 North America
6.1 North America Angiotensin Receptor Antagonists by Country
6.1.1 North America Angiotensin Receptor Antagonists Sales by Country
6.1.2 North America Angiotensin Receptor Antagonists Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Angiotensin Receptor Antagonists Market Facts & Figures by Type
6.3 North America Angiotensin Receptor Antagonists Market Facts & Figures by Application
7 Europe
7.1 Europe Angiotensin Receptor Antagonists by Country
7.1.1 Europe Angiotensin Receptor Antagonists Sales by Country
7.1.2 Europe Angiotensin Receptor Antagonists Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Angiotensin Receptor Antagonists Market Facts & Figures by Type
7.3 Europe Angiotensin Receptor Antagonists Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Angiotensin Receptor Antagonists by Region
8.1.1 Asia Pacific Angiotensin Receptor Antagonists Sales by Region
8.1.2 Asia Pacific Angiotensin Receptor Antagonists Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Angiotensin Receptor Antagonists Market Facts & Figures by Type
8.3 Asia Pacific Angiotensin Receptor Antagonists Market Facts & Figures by Application
9 Latin America
9.1 Latin America Angiotensin Receptor Antagonists by Country
9.1.1 Latin America Angiotensin Receptor Antagonists Sales by Country
9.1.2 Latin America Angiotensin Receptor Antagonists Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Angiotensin Receptor Antagonists Market Facts & Figures by Type
9.3 Central & South America Angiotensin Receptor Antagonists Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Angiotensin Receptor Antagonists by Country
10.1.1 Middle East and Africa Angiotensin Receptor Antagonists Sales by Country
10.1.2 Middle East and Africa Angiotensin Receptor Antagonists Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Angiotensin Receptor Antagonists Market Facts & Figures by Type
10.3 Middle East and Africa Angiotensin Receptor Antagonists Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Angiotensin Receptor Antagonists Products Offered
11.1.5 Pfizer Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Angiotensin Receptor Antagonists Products Offered
11.2.5 Novartis Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Angiotensin Receptor Antagonists Products Offered
11.3.5 Merck Related Developments
11.4 Astra Zeneca
11.4.1 Astra Zeneca Corporation Information
11.4.2 Astra Zeneca Description and Business Overview
11.4.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Astra Zeneca Angiotensin Receptor Antagonists Products Offered
11.4.5 Astra Zeneca Related Developments
11.5 Jhonson and Johnson
11.5.1 Jhonson and Johnson Corporation Information
11.5.2 Jhonson and Johnson Description and Business Overview
11.5.3 Jhonson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Jhonson and Johnson Angiotensin Receptor Antagonists Products Offered
11.5.5 Jhonson and Johnson Related Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Corporation Information
11.6.2 Eli Lilly Description and Business Overview
11.6.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eli Lilly Angiotensin Receptor Antagonists Products Offered
11.6.5 Eli Lilly Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Angiotensin Receptor Antagonists Products Offered
11.7.5 Sanofi Related Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Corporation Information
11.8.2 Bristol-Myers Squibb Description and Business Overview
11.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bristol-Myers Squibb Angiotensin Receptor Antagonists Products Offered
11.8.5 Bristol-Myers Squibb Related Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Description and Business Overview
11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Angiotensin Receptor Antagonists Products Offered
11.9.5 Bayer Related Developments
11.10 GSK
11.10.1 GSK Corporation Information
11.10.2 GSK Description and Business Overview
11.10.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.10.4 GSK Angiotensin Receptor Antagonists Products Offered
11.10.5 GSK Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Angiotensin Receptor Antagonists Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Angiotensin Receptor Antagonists Market Estimates and Projections by Region
12.1.1 Global Angiotensin Receptor Antagonists Sales Forecast by Regions 2021-2026
12.1.2 Global Angiotensin Receptor Antagonists Revenue Forecast by Regions 2021-2026
12.2 North America Angiotensin Receptor Antagonists Market Size Forecast (2021-2026)
12.2.1 North America: Angiotensin Receptor Antagonists Sales Forecast (2021-2026)
12.2.2 North America: Angiotensin Receptor Antagonists Revenue Forecast (2021-2026)
12.2.3 North America: Angiotensin Receptor Antagonists Market Size Forecast by Country (2021-2026)
12.3 Europe Angiotensin Receptor Antagonists Market Size Forecast (2021-2026)
12.3.1 Europe: Angiotensin Receptor Antagonists Sales Forecast (2021-2026)
12.3.2 Europe: Angiotensin Receptor Antagonists Revenue Forecast (2021-2026)
12.3.3 Europe: Angiotensin Receptor Antagonists Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Angiotensin Receptor Antagonists Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Angiotensin Receptor Antagonists Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Angiotensin Receptor Antagonists Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Angiotensin Receptor Antagonists Market Size Forecast by Region (2021-2026)
12.5 Latin America Angiotensin Receptor Antagonists Market Size Forecast (2021-2026)
12.5.1 Latin America: Angiotensin Receptor Antagonists Sales Forecast (2021-2026)
12.5.2 Latin America: Angiotensin Receptor Antagonists Revenue Forecast (2021-2026)
12.5.3 Latin America: Angiotensin Receptor Antagonists Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Angiotensin Receptor Antagonists Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Angiotensin Receptor Antagonists Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Angiotensin Receptor Antagonists Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Angiotensin Receptor Antagonists Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Angiotensin Receptor Antagonists Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Angiotensin Receptor Antagonists Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Angiotensin Receptor Antagonists Market Segments
Table 2. Ranking of Global Top Angiotensin Receptor Antagonists Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Valsartan
Table 5. Major Manufacturers of Telmisartan
Table 6. Major Manufacturers of Losartan
Table 7. Major Manufacturers of Irbesartan
Table 8. Major Manufacturers of Azilsartan
Table 9. Major Manufacturers of Olmesartan
Table 10. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Angiotensin Receptor Antagonists Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Angiotensin Receptor Antagonists Sales by Regions 2015-2020 (K Units)
Table 13. Global Angiotensin Receptor Antagonists Sales Market Share by Regions (2015-2020)
Table 14. Global Angiotensin Receptor Antagonists Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Angiotensin Receptor Antagonists Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Angiotensin Receptor Antagonists Sales Share by Manufacturers (2015-2020)
Table 17. Global Angiotensin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Angiotensin Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Receptor Antagonists as of 2019)
Table 19. Angiotensin Receptor Antagonists Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Angiotensin Receptor Antagonists Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Angiotensin Receptor Antagonists Price (2015-2020) (USD/Unit)
Table 22. Angiotensin Receptor Antagonists Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Angiotensin Receptor Antagonists Product Type
Table 24. Date of International Manufacturers Enter into Angiotensin Receptor Antagonists Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Angiotensin Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 27. Global Angiotensin Receptor Antagonists Sales Share by Type (2015-2020)
Table 28. Global Angiotensin Receptor Antagonists Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Angiotensin Receptor Antagonists Revenue Share by Type (2015-2020)
Table 30. Angiotensin Receptor Antagonists Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Angiotensin Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 32. Global Angiotensin Receptor Antagonists Sales Share by Application (2015-2020)
Table 33. North America Angiotensin Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 34. North America Angiotensin Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 35. North America Angiotensin Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Angiotensin Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 37. North America Angiotensin Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 38. North America Angiotensin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 39. North America Angiotensin Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 40. North America Angiotensin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 41. Europe Angiotensin Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 42. Europe Angiotensin Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 43. Europe Angiotensin Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Angiotensin Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 45. Europe Angiotensin Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 46. Europe Angiotensin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 47. Europe Angiotensin Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 48. Europe Angiotensin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Angiotensin Receptor Antagonists Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Angiotensin Receptor Antagonists Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Angiotensin Receptor Antagonists Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Angiotensin Receptor Antagonists Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Angiotensin Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Angiotensin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Angiotensin Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Angiotensin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 57. Latin America Angiotensin Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 58. Latin America Angiotensin Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Angiotensin Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Angiotensin Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 61. Latin America Angiotensin Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 62. Latin America Angiotensin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 63. Latin America Angiotensin Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 64. Latin America Angiotensin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Angiotensin Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Angiotensin Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Angiotensin Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Angiotensin Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Angiotensin Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Major Businesses
Table 75. Pfizer Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Pfizer Product
Table 77. Pfizer Recent Development
Table 78. Novartis Corporation Information
Table 79. Novartis Description and Major Businesses
Table 80. Novartis Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Novartis Product
Table 82. Novartis Recent Development
Table 83. Merck Corporation Information
Table 84. Merck Description and Major Businesses
Table 85. Merck Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Merck Product
Table 87. Merck Recent Development
Table 88. Astra Zeneca Corporation Information
Table 89. Astra Zeneca Description and Major Businesses
Table 90. Astra Zeneca Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Astra Zeneca Product
Table 92. Astra Zeneca Recent Development
Table 93. Jhonson and Johnson Corporation Information
Table 94. Jhonson and Johnson Description and Major Businesses
Table 95. Jhonson and Johnson Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Jhonson and Johnson Product
Table 97. Jhonson and Johnson Recent Development
Table 98. Eli Lilly Corporation Information
Table 99. Eli Lilly Description and Major Businesses
Table 100. Eli Lilly Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Eli Lilly Product
Table 102. Eli Lilly Recent Development
Table 103. Sanofi Corporation Information
Table 104. Sanofi Description and Major Businesses
Table 105. Sanofi Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Sanofi Product
Table 107. Sanofi Recent Development
Table 108. Bristol-Myers Squibb Corporation Information
Table 109. Bristol-Myers Squibb Description and Major Businesses
Table 110. Bristol-Myers Squibb Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Bristol-Myers Squibb Product
Table 112. Bristol-Myers Squibb Recent Development
Table 113. Bayer Corporation Information
Table 114. Bayer Description and Major Businesses
Table 115. Bayer Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Bayer Product
Table 117. Bayer Recent Development
Table 118. GSK Corporation Information
Table 119. GSK Description and Major Businesses
Table 120. GSK Angiotensin Receptor Antagonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. GSK Product
Table 122. GSK Recent Development
Table 123. Teva Pharmaceutical Corporation Information
Table 124. Teva Pharmaceutical Description and Major Businesses
Table 125. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Teva Pharmaceutical Product
Table 127. Teva Pharmaceutical Recent Development
Table 128. Global Angiotensin Receptor Antagonists Sales Forecast by Regions (2021-2026) (K Units)
Table 129. Global Angiotensin Receptor Antagonists Sales Market Share Forecast by Regions (2021-2026)
Table 130. Global Angiotensin Receptor Antagonists Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 131. Global Angiotensin Receptor Antagonists Revenue Market Share Forecast by Regions (2021-2026)
Table 132. North America: Angiotensin Receptor Antagonists Sales Forecast by Country (2021-2026) (K Units)
Table 133. North America: Angiotensin Receptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Europe: Angiotensin Receptor Antagonists Sales Forecast by Country (2021-2026) (K Units)
Table 135. Europe: Angiotensin Receptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Asia Pacific: Angiotensin Receptor Antagonists Sales Forecast by Region (2021-2026) (K Units)
Table 137. Asia Pacific: Angiotensin Receptor Antagonists Revenue Forecast by Region (2021-2026) (US$ Million)
Table 138. Latin America: Angiotensin Receptor Antagonists Sales Forecast by Country (2021-2026) (K Units)
Table 139. Latin America: Angiotensin Receptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Middle East and Africa: Angiotensin Receptor Antagonists Sales Forecast by Country (2021-2026) (K Units)
Table 141. Middle East and Africa: Angiotensin Receptor Antagonists Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Main Points Interviewed from Key Angiotensin Receptor Antagonists Players
Table 146. Angiotensin Receptor Antagonists Customers List
Table 147. Angiotensin Receptor Antagonists Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin Receptor Antagonists Product Picture
Figure 2. Global Angiotensin Receptor Antagonists Sales Market Share by Type in 2020 & 2026
Figure 3. Valsartan Product Picture
Figure 4. Telmisartan Product Picture
Figure 5. Losartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Azilsartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Global Angiotensin Receptor Antagonists Sales Market Share by Application in 2020 & 2026
Figure 10. Hypertension
Figure 11. Cardiovascular Diseases
Figure 12. Kidney Diseases
Figure 13. Other
Figure 14. Angiotensin Receptor Antagonists Report Years Considered
Figure 15. Global Angiotensin Receptor Antagonists Market Size 2015-2026 (US$ Million)
Figure 16. Global Angiotensin Receptor Antagonists Sales 2015-2026 (K Units)
Figure 17. Global Angiotensin Receptor Antagonists Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2015-2020)
Figure 19. Global Angiotensin Receptor Antagonists Sales Market Share by Region in 2019
Figure 20. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2015-2020)
Figure 21. Global Angiotensin Receptor Antagonists Revenue Market Share by Region in 2019
Figure 22. Global Angiotensin Receptor Antagonists Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Angiotensin Receptor Antagonists Revenue in 2019
Figure 24. Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Angiotensin Receptor Antagonists Sales Market Share by Type (2015-2020)
Figure 26. Global Angiotensin Receptor Antagonists Sales Market Share by Type in 2019
Figure 27. Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2015-2020)
Figure 28. Global Angiotensin Receptor Antagonists Revenue Market Share by Type in 2019
Figure 29. Global Angiotensin Receptor Antagonists Market Share by Price Range (2015-2020)
Figure 30. Global Angiotensin Receptor Antagonists Sales Market Share by Application (2015-2020)
Figure 31. Global Angiotensin Receptor Antagonists Sales Market Share by Application in 2019
Figure 32. Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2015-2020)
Figure 33. Global Angiotensin Receptor Antagonists Revenue Market Share by Application in 2019
Figure 34. North America Angiotensin Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Angiotensin Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Angiotensin Receptor Antagonists Sales Market Share by Country in 2019
Figure 37. North America Angiotensin Receptor Antagonists Revenue Market Share by Country in 2019
Figure 38. U.S. Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Angiotensin Receptor Antagonists Market Share by Type in 2019
Figure 43. North America Angiotensin Receptor Antagonists Market Share by Application in 2019
Figure 44. Europe Angiotensin Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Angiotensin Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Angiotensin Receptor Antagonists Sales Market Share by Country in 2019
Figure 47. Europe Angiotensin Receptor Antagonists Revenue Market Share by Country in 2019
Figure 48. Germany Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Angiotensin Receptor Antagonists Market Share by Type in 2019
Figure 59. Europe Angiotensin Receptor Antagonists Market Share by Application in 2019
Figure 60. Asia Pacific Angiotensin Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Angiotensin Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Angiotensin Receptor Antagonists Sales Market Share by Region in 2019
Figure 63. Asia Pacific Angiotensin Receptor Antagonists Revenue Market Share by Region in 2019
Figure 64. China Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Angiotensin Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Angiotensin Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam A

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs